510(k) Report

510(k) · Cleared

Recalled · 2008

Vectra Transportable Combo and Stim (Specialty Line Dealers); Intelect Transportable Combo and Stim (General Line Dealer

K040285510(k) TraditionalCleared Apr 12, 200466-day reviewClass II21 CFR 890.5860Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Chattanooga Group · IMG Stimulator, Ultrasound And Muscle, For Use In Applying Therapeutic Deep Heat

Cleared on Apr 12, 2004 after a 66-day review. FDA’s file for it is a 510(k) statement, which names no predicate. It has been recalled once.

Decided
Apr 12, 2004
Review
66 days
Class
Class II
Product code
IMG
Recalls
1
Predicates
0

FDA’s file for it is a 510(k) statement, which names no predicate.

FIG. 1 — Lineage of K040285Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in IMG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new IMG device

  1. #1 K244041 Ultrasound Therapy Workstation (XMS-UET2)score 10.7 · 3 generations · no Class I recall
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Feb 28, 2008Not classifiedZ-1639-2008Component design/selectionDevice may fail to administer therapy during use.

No ancestor or descendant has a Class I recall.

How does its category compare?

All IMG devices

IMG Stimulator, Ultrasound And Muscle, For Use In Applying Therapeutic Deep Heat: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · IMG

1in 2025

2007: 32010: 12011: 32012: 22015: 22016: 12025: 1
2007high 3 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · IMG

226in 2011

2007: 110 days median2011: 226 days median
2007high 226 (2011) · low 110 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · IMG

2in 2008

2008: 2
2007high 2 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · IMG

9in 2025

2008: 372009: 262010: 62011: 212012: 62013: 42014: 32015: 42016: 72017: 32019: 142020: 102021: 132022: 142023: 72024: 52025: 9
2007high 37 (2008) · low 0 (2007)2025

MAUDE reports naming product code IMG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007311000
20080—237
20090—026
20101—06
20113226021
20122—06
20130—04
20140—03
20152—04
20161—07
20170—03
20180—00
20190—014
20200—010
20210—013
20220—014
20230—07
20240—05
20251—09
20260—0—

What is it indicated for?

For VMS, VMS Burst, Russian, Monophasic Hi-Volt (NMES), Interferential and Piremodulated (IFS) Relaxation of Muscle Spasms Prevention or retardation of disuse atrophy Increasing local blood circulation Muscle re-education Maintaining or increasing range of motion Immediate postsurgical stimulation of calf muscles to prevent venous thrombosis Additionally for Microcurrent, Interferential, Premodulated (IFS), VMS, VMS Burst, Asymmetrical Biphasic (TENS)…

Read the full statement (193 words)

For VMS, VMS Burst, Russian, Monophasic Hi-Volt (NMES), Interferential and Piremodulated (IFS)

Relaxation of Muscle Spasms

Prevention or retardation of disuse atrophy

Increasing local blood circulation

Muscle re-education

Maintaining or increasing range of motion

Immediate postsurgical stimulation of calf muscles to prevent venous thrombosis

Additionally for Microcurrent, Interferential, Premodulated (IFS), VMS, VMS Burst, Asymmetrical Biphasic (TENS) and Symmetrical Biphasic (TENS)

Symptomatic relief or management of chronic, intractable pain

Post-traumatic acute pain

Post-surgical acute pain

For FES

Stimulation of the muscles in the leg and ankle of partially paralyzed patients to provide flexion of the foot and thus improve the patient's gait

For DC Continuous Mode

[Relaxation of muscle spasm

For Ultrasound

Application of therapeutic deep heat for the treatment of selected sub-chronic and chronic medical conditions such as:

1. Relief of pain, muscle spasms and joint contractures

2. Relief of pain, muscle spasms and joint contractures that may be associated with:

a) Adhesive capsulitis

b) Bursitis with slight calcification

c) Myositis

d) Soft tissue injuries

e) Shortened tendons due to past injuries and scar tissues

3. Relief of sub-chronic and chronic pain and joint contractures resulting from:

a) Capsular tightness

b) Capsular scarring

Indications for use as stated in the FDA 510(k) statement.

Cite this page

510(k) Report. “K040285: Vectra Transportable Combo and Stim (Specialty Line Dealers); Intelect Transportable Combo and Stim (General Line Dealer.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K040285

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Page last updated Nov 3, 2026